Clinical trial
A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY…
NCT00474526 · Novartis Vaccines, Industry · Completed
Key facts
| NCT number | NCT00474526 |
|---|---|
| Title | A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Vaccine In Infants |
| Official title | A Phase 3, Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Safety and Immunogenicity of Novartis Meningococcal ACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants |
| Lead sponsor | Novartis Vaccines, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Meningitis, Meningococcal |
| Intervention type | Biological |
| Interventions | Meningococcal ACWY Conjugate Vaccine, DTaP-IPV-HBV, Hib, Rotavirus, Pneumococcal 7-valent Conjugate Vaccine, HAV, MMR-V, DTaP |
| Enrollment | 4,545 |
| Start date | Mar 1, 2007 |
| Primary completion | Sep 1, 2008 |
| Completion | Nov 1, 2009 |
| First posted | May 17, 2007 |
| Last update posted | Mar 24, 2014 |
| Countries | Argentina, Colombia, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: